Endo Tools Therapeutics (ETT) is a privately held medical device company in Gosselies, Belgium. ETT is dedicated to the development of innovative devices providing new means of therapeutic interventions for gastroenterologists. It is a spin-off from Université libre de Bruxelles, based on a collaboration between the engineers of the engineering school and the gastroenterologists from Erasme Hospital.
ETT has developed a triangulation platform, Endomina, that adds therapeutic channels and degrees of freedom for interventional gastroenterology. Its platform is now CE marked and has been succesfully used by physicians during more than 300 procedures. ETT is developing other versions of the devices, adapted for smaller environments.
2 articles describing procedures using Endomina and their results have been published : one in GIE in 2017 and a second one in Endoscopy in 2018. A third article, reporting RCT results, is currently in press in Gut.
Note: this website contains general information intended for medical professionals only; information on this website should be treated as such, not as advice; this website is not intended for the United States.
Press Release : Endo Tools Therapeutics secures €8 million ($9.5M) in Series D funding led by White Fund
Developing innovative, minimally invasive medical devices for gastroenterologists, company plans to seek regulatory clearance in the US and reimbursement in European countries Gosselies, Belgium, January 19, 2021 – Endo Tools Therapeutics (ETT), developers of advanced...
Due to covid-19 situation, we won't participate to physical conferences until further notice. Please don't hesitate to contact us for any information or update on our products and results.
Endo Tools Therapeutics representatives are present at the 27th United European Gastroenterology Week (UEGW) in Bercelona (21-23 October, 2019). Interested in arranging a meeting? Contact us at: email@example.com